Chu A - Search Results

1

Bioinformatics analysis and experimental verification of NLRX1 as a prognostic factor for esophageal squamous cell carcinoma.

Zhou L, Gan L, Sun C, Chu A, Yang M, Liu Z. Zhou L, et al. Among authors: chu a. Oncol Lett. 2024 Apr 11;27(6):264. doi: 10.3892/ol.2024.14397. eCollection 2024 Jun. Oncol Lett. 2024. PMID: 38659420 Free PMC article.

2

High incidence of coding gene mutations in mitochondrial DNA in esophageal cancer.

Liu ZW, Guo ZJ, Chu AL, Zhang Y, Liang B, Guo X, Chai T, Song R, Hou G, Yuan JJ. Liu ZW, et al. Among authors: chu al. Mol Med Rep. 2017 Dec;16(6):8537-8541. doi: 10.3892/mmr.2017.7663. Epub 2017 Sep 29. Mol Med Rep. 2017. PMID: 28990096

3

Identification of abnormal nuclear and mitochondrial genes in esophageal cancer cells.

Liu Z, Chai T, Zhang Y, Chu A, Liang B, Guo X, Guo Z, Song R, Hou G, Yuan J, Liu Y, Zhang Y. Liu Z, et al. Among authors: chu a. Mol Med Rep. 2018 Feb;17(2):2817-2826. doi: 10.3892/mmr.2017.8228. Epub 2017 Dec 8. Mol Med Rep. 2018. PMID: 29257265 Free PMC article.

4

Experimental Study and Clinical Observation on the Improvement Effect of Lienal Polypeptide on Blood Toxicity and Immune Injury Induced by Radiotherapy.

Chu A, Song R, Hou G, Yuan J, Wang C, Yang Y, Qin N, Liu Y, Liang B, Zhang Y, Liu Z. Chu A, et al. Genet Test Mol Biomarkers. 2020 Feb;24(2):73-77. doi: 10.1089/gtmb.2019.0138. Genet Test Mol Biomarkers. 2020. PMID: 31999489 Free PMC article.

5

Knockdown of circMFN2 inhibits cell progression and glycolysis by miR-198/CUL4B pathway in ovarian cancer.

Song R, Chai T, Liu J, Chu A, Sun C, Liu Z. Song R, et al. Among authors: chu a. J Biochem Mol Toxicol. 2023 Aug;37(8):e23383. doi: 10.1002/jbt.23383. Epub 2023 May 9. J Biochem Mol Toxicol. 2023. PMID: 37158446

6

Hsa_circ_0052611 and mir-767-5p guide the warburg effect, migration, and invasion of BRCA cells through modulating SCAI.

Wang X, Liu Z, Chu A, Song R, Liu S, Chai T, Sun C. Wang X, et al. Among authors: chu a. J Bioenerg Biomembr. 2023 Oct;55(5):381-396. doi: 10.1007/s10863-023-09985-4. Epub 2023 Sep 25. J Bioenerg Biomembr. 2023. PMID: 37743442

7

PARP inhibitors combined with radiotherapy: are we ready?

Sun C, Chu A, Song R, Liu S, Chai T, Wang X, Liu Z. Sun C, et al. Among authors: chu a. Front Pharmacol. 2023 Oct 26;14:1234973. doi: 10.3389/fphar.2023.1234973. eCollection 2023. Front Pharmacol. 2023. PMID: 37954854 Free PMC article. Review.

8

Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center's decade of experience.

Sun C, España S, Richarz N, Solé-Blanch C, Boada A, Martinez-Cardús A, Chu A, Liu Z, Manzano JL. Sun C, et al. Among authors: chu a. Front Oncol. 2024 Feb 21;14:1322116. doi: 10.3389/fonc.2024.1322116. eCollection 2024. Front Oncol. 2024. PMID: 38450188 Free PMC article.

9

Circ-POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR-876-5p/FYN axis.

Chu A, Sun C, Liu Z, Liu S, Li M, Song R, Gan L, Wang Y, Fan R. Chu A, et al. Thorac Cancer. 2024 May;15(13):1082-1094. doi: 10.1111/1759-7714.15273. Epub 2024 Mar 29. Thorac Cancer. 2024. PMID: 38553795 Free PMC article.

10

GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration.

Gan L, Zhou L, Chu A, Sun C, Wang Y, Yang M, Liu Z. Gan L, et al. Among authors: chu a. Mol Biol Rep. 2024 Nov 13;51(1):1149. doi: 10.1007/s11033-024-10070-1. Mol Biol Rep. 2024. PMID: 39535578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,722 results

Search Page

Filters